US OptionsDetailed Quotes

ARCT240517C50000

Watchlist

0.49
0.000.00%

15min DelayClose Mar 26 09:47 ET

0.00High0.00Low

Arcturus Therapeutics Stock Discussion

Moomoo AI

Mar 9 20:57

Analysts maintain loss per share estimates for next year with no major changes to revenue estimates. However, the company's performance is expected to underperform the wider industry. The steady consensus price target indicates that reduced loss estimates may not positively impact the stock's long-term valuation.

Analysts Have Made A Financial Statement On Arcturus Therapeutics Holdings Inc.'s (NASDAQ:ARCT) Yearly Report

Moomoo AI

Feb 28 20:46

Despite Arcturus Therapeutics Holdings Inc.'s strong run, its P/S ratio remains low due to a weak revenue outlook. Investors believe the potential for revenue improvement doesn't justify a higher P/S ratio, forming a barrier for the share price.

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Stock Catapults 28% Though Its Price And Business Still Lag The Industry

SlowndEasyTrades

Feb 10 02:29

$Arcturus Therapeutics(ARCT.US)$ in game 👀✈️

Moomoo AI

Feb 7 02:49

The recent improvement in total shareholder return could indicate that the business is getting better over time. However, there are 2 warning signs that investors should be aware of. The sentiment around the company seems to be positive lately.